Cargando…
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Background/Aim: There is a strong association between malignancy and histone deacetylases (HDACs). Histone deacetylase inhibitors (HDACIs) are now being tested as antitumor agents in various clinical trials. We aimed to assess the clinical importance of HDAC-2 in breast cancer (BC). Materials and Me...
Autores principales: | Garmpis, Nikolaos, Damaskos, Christos, Dimitroulis, Dimitrios, Kouraklis, Gregory, Garmpi, Anna, Sarantis, Panagiotis, Koustas, Evangelos, Patsouras, Alexandros, Psilopatis, Iason, Antoniou, Efstathios A., Karamouzis, Michail V., Kontzoglou, Konstantinos, Nonni, Afroditi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604828/ https://www.ncbi.nlm.nih.gov/pubmed/36294811 http://dx.doi.org/10.3390/jpm12101672 |
Ejemplares similares
-
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023) -
FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
por: Psilopatis, Iason, et al.
Publicado: (2023) -
Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities
por: Garmpis, Nikolaos, et al.
Publicado: (2021) -
Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic Review
por: Damaskos, Christos, et al.
Publicado: (2022) -
The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)